These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21479787)

  • 21. Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash.
    Nicolatou-Galitis O; Dardoufas K; Markoulatos P; Sotiropoulou-Lontou A; Kyprianou K; Kolitsi G; Pissakas G; Skarleas C; Kouloulias V; Papanicolaou V; Legakis NJ; Velegraki A
    J Oral Pathol Med; 2001 Sep; 30(8):471-80. PubMed ID: 11545238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral and pharyngeal candidiasis. Topical agents for management and prevention.
    Epstein JB
    Postgrad Med; 1989 Apr; 85(5):257-8, 263-5, 268-9. PubMed ID: 2648372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
    Belazi M; Velegraki A; Koussidou-Eremondi T; Andreadis D; Hini S; Arsenis G; Eliopoulou C; Destouni E; Antoniades D
    Oral Microbiol Immunol; 2004 Dec; 19(6):347-51. PubMed ID: 15491459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perillaldehyde: A promising antifungal agent to treat oropharyngeal candidiasis.
    Chen L; Qu S; Yang K; Liu M; Li YX; Keller NP; Zeng X; Tian J
    Biochem Pharmacol; 2020 Oct; 180():114201. PubMed ID: 32822688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic treatment of mycotic mucositis in radiotherapy of patients with head and neck cancers.
    Koc M; Aktas E
    Jpn J Clin Oncol; 2003 Feb; 33(2):57-60. PubMed ID: 12629054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural Compounds with Antimicrobial Activities in Oral Candida Infections during Head and Neck Radiotherapy.
    Imperia E; Bonincontro G; Altomare A; Simonetti G; Gherardi G; Brasili E; Badiali C; Bove M; Pasqua G; De Gara L; Cicala M; Guarino MPL
    Chemotherapy; 2024; 69(2):65-84. PubMed ID: 37963442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oropharyngeal candidiasis: a new treatment option.
    Klotz SA
    Clin Infect Dis; 2006 Apr; 42(8):1187-8. PubMed ID: 16575740
    [No Abstract]   [Full Text] [Related]  

  • 28. Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients.
    Dronda F; Alonso-Sanz M; Laguna F; Chaves F; Martínez-Suárez JV; Rodríguez-Tudela JL; González-López A; Valencia E
    Eur J Clin Microbiol Infect Dis; 1996 Jun; 15(6):446-52. PubMed ID: 8839637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy.
    Nicolatou-Galitis O; Velegraki A; Sotiropoulou-Lontou A; Dardoufas K; Kouloulias V; Kyprianou K; Kolitsi G; Skarleas C; Pissakas G; Papanicolaou VS; Kouvaris J
    Support Care Cancer; 2006 Jan; 14(1):44-51. PubMed ID: 15947956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of fluconazole as antimycotic prophylaxis in radiotherapy of patients with head and neck tumors].
    Mücke R; Kaben U; Libera T; Knauerhase H; Ziegler PG; Hamann D; Strietzel M
    Mycoses; 1997; 40 Suppl 1():53-5. PubMed ID: 9417514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients.
    Lopez-Ribot JL; McAtee RK; Perea S; Kirkpatrick WR; Rinaldi MG; Patterson TF
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1621-30. PubMed ID: 10390213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group.
    de Repentigny L; Ratelle J
    Chemotherapy; 1996; 42(5):374-83. PubMed ID: 8874977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluconazole prophylaxis in patients with head and neck tumours undergoing radiation and radiochemotherapy.
    Mücke R; Kaben U; Libera T; Knauerhase H; Ziegler PG; Hamann D; Strietzel M
    Mycoses; 1998 Nov; 41(9-10):421-3. PubMed ID: 9916467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifungal therapy in oropharyngeal mycotic infections.
    Epstein JB
    Oral Surg Oral Med Oral Pathol; 1990 Jan; 69(1):32-41. PubMed ID: 2404226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oropharyngeal candidiasis: a review of its clinical spectrum and current therapies.
    Epstein JB; Polsky B
    Clin Ther; 1998; 20(1):40-57. PubMed ID: 9522103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients.
    Redding SW; Kirkpatrick WR; Dib O; Fothergill AW; Rinaldi MG; Patterson TF
    Spec Care Dentist; 2000; 20(5):178-81. PubMed ID: 11203894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of Candida infections as an adverse effect upon head and neck cancer patients undergoing therapeutic radiation and the effect of antimycotic treatment.
    Poland JM
    Mycoses; 1989; 32 Suppl 2():39-41. PubMed ID: 2700220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signs, symptoms and the prevalence of fungi detected from the oral cavity and pharynx of radiotherapy subjects with head and neck tumors, and their susceptibility to chemotherapeutics.
    Kurnatowski P; Moqbil S; Kaczmarczyk D
    Ann Parasitol; 2014; 60(3):207-13. PubMed ID: 25281818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients.
    Quereda C; Polanco AM; Giner C; Sánchez-Sousa A; Pereira E; Navas E; Fortún J; Guerrero A; Baquero F
    Eur J Clin Microbiol Infect Dis; 1996 Jan; 15(1):30-7. PubMed ID: 8641300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues.
    Darouiche RO
    Clin Infect Dis; 1998 Feb; 26(2):259-72; quiz 273-4. PubMed ID: 9502438
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.